Figure 2 | British Journal of Cancer

Figure 2

From: Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer

Figure 2

Analysis of all 177 patients treated with neoadjuvant chemotherapy (NAC) revealed no significant difference in disease-free survival (DFS) associated with AR expression ( P =0.090, log-rank) ( A). No significant difference in DFS according to AR expression was observed in patients with non-TNBC (P=0.628, log-rank) (B). A significantly shortened non-recurrence period was observed in patients with AR-expressing tumours, when the analysis was limited to patients with TNBC (P=0.006, log-rank) (C).

Back to article page